IP Library Granted Patent US 7,786,103
Granted Patent B2
US 7,786,103 · App. 11/872,855 · Granted Aug 31, 2010

Method for isolating an intestinal cholesterol binding protein

Assignee: Sanofi-Aventis Deutschland GmbH
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,786,103
App. No.
11/872,855
Granted
Aug 31, 2010
Kind
B2
Abstract

The invention describes a method for isolating an intestinal protein which is able to bind cholesterol and/or cholesterol uptake inhibitors.

Claims (27)

1. A method for isolating a 145 kDa protein capable of specifically binding cholesterol absorption inhibitors, comprising the steps of:

i) incubating mammalian intestinal tissue or cells with a photoreactive inhibitor of cholesterol uptake which is radioactively labeled and biotin-tagged,

ii) solubilizing said intestinal cells and separating the supernatant from the cell debris,

iii) adding said supernatant onto streptavidin-agarose,

iv) adding the eluate of said streptavidin-agarose onto a SDS-PAGE and

v) excising the proteins running in a size range of 140 to 150 kDa and eluting said proteins,

vi) isolating a complex comprising the 145 kDa protein bound to the photoreactive inhibitor of cholesterol uptake and

vii) separating the 145 kDa protein from the cholesterol absorption inhibitor,

wherein the photoreactive inhibitor of cholesterol uptake which is biotin tagged has the following structure:

2. The method of claim 1 wherein said intestinal tissue or cells are from an intestinal cell culture or ileal brush border cells from human, rat, mouse or rabbit.

3. A method for isolating a complex formed by a purified 145 kDa protein capable of specifically binding cholesterol absorption inhibitors and a cholesterol absorption inhibitor, comprising the steps of:

i) incubating mammalian intestinal tissue or cells with a cholesterol absorption inhibitor that is a photoreactive inhibitor of cholesterol uptake which is radioactively labeled and biotin-tagged,

ii) solubilizing said intestinal cells and separating the supernatant from the cell debris,

iii) adding said supernatant onto streptavidin-agarose,

iv) adding the eluate of said streptavidin-agarose onto a SDS-PAGE and

v) excising the proteins running in a size range of 140 to 150 kDa and eluting said proteins bound to said cholesterol absorption inhibitor , and

iv) isolating the complex,

said cholesterol absorption inhibitor having the following structure

4. A method for isolating a complex formed by a purified 145 kDa protein capable of specifically binding cholesterol absorption inhibitors and a cholesterol absorption inhibitor, comprising the steps of:

i) incubating mammalian intestinal tissue or cells with a photoreactive inhibitor of cholesterol uptake which is biotin-tagged,

ii) solubilizing said intestinal cells and separating the supernatant from the cell debris,

iii) adding said supernatant onto streptavidin-agarose,

iv) adding the eluate of said streptavidin-agarose onto a SDS-PAGE and

v) excising the proteins running in a size range of 140 to 150 kDa and eluting said proteins bound to said cholesterol absorption inhibitor, and

iv) isolating the complex,

said photoreactive inhibitor having the following structure of Formula I:

wherein R shall be selected from one of the following groups a) and b):

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 28, 2010
From: KRAMER, WERNER; FRICK, WENDELIN
To: AVENTIS PHARMA DEUTSCHLAND GMBH
Reel/Frame 024602/0435 →
CHANGE OF NAME Recorded Jun 28, 2010
From: AVENTIS PHARMA DEUTSCHLAND GMBH
To: SANOFI-AVENTIS DEUTSCHLAND GMBH
Reel/Frame 024605/0602 →
Priority Claims (1)
EP 02017504 · Aug 6, 2002 · regional
Continuity (2)
Division 1063500800 · Aug 6, 2003
Related Publication 20080167451A1 · Jul 10, 2008